has entered into a strategic alliance withAmbulatory Monitoring, Inc. (AMI), a medical device and service company.

AMI, located in Ardsley, NY, provides equipment for monitoring physiological functioning in ambulatory  subjects.  The company’s series of Motionlogger® Actigraphs are  commercial devices for 24-hour monitoring of activity and sleep and have  been validated through use in hundreds of studies in numerous clinical  populations.  AMI’s activity monitors can be applied in clinical trials of  therapeutics for sleep, psychiatric, pain, hyperactivity, dermatologic  (e.g., itch), and cardiovascular disorders, among others.  AMI also providesthe original PVT-192 Psychomotor Vigilance Task Monitor.

The alliance brings together AMI’s instrumentation with Clinilabs’ core  laboratory.  Clinilabs’ core laboratory aggregates and  processes electrocardiographic (ECG), polysomnographic (PSG),  electroencephalographic (EEG), and electromyographic (EMG) data for clinical  studies, offering pharmaceutical companies centralized services that  standardize data obtained in multicenter trials.  Centralized actigraphy has  been offered jointly by Clinilabs and AMI since 2005.